Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. uri icon

Overview

publication date

  • June 1, 2023

Research

keywords

  • Mitomycin
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 85163284601

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2023.05.028

PubMed ID

  • 37270391

Additional Document Info

volume

  • 84

issue

  • 5